Lancy Co., Ltd. (SHE:002612)
China · Delayed Price · Currency is CNY 17.68
+0.07 (0.40%)
Aug 1, 2025, 2:45 PM CST
Sage Therapeutics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 261.84 | 257.2 | 253.69 | 21.37 | 173.45 | 142.04 | Upgrade |
Depreciation & Amortization | 244.34 | 244.34 | 253.32 | 202.25 | 155.22 | 47.04 | Upgrade |
Other Amortization | 83.31 | 83.31 | 65.28 | 47.91 | 37.35 | 32.05 | Upgrade |
Loss (Gain) From Sale of Assets | -1.04 | -1.04 | 2.31 | 1.09 | -0.68 | 5.88 | Upgrade |
Asset Writedown & Restructuring Costs | 3.07 | 3.07 | 1.83 | 1.44 | - | - | Upgrade |
Loss (Gain) From Sale of Investments | -24.5 | -24.5 | -46.71 | -51.29 | -56.51 | -99.29 | Upgrade |
Provision & Write-off of Bad Debts | -2.32 | -2.32 | -3.65 | 1.97 | 16.59 | 6.44 | Upgrade |
Other Operating Activities | 47.4 | 105.19 | 113.06 | 146.02 | 96.06 | 34.9 | Upgrade |
Change in Accounts Receivable | 73.69 | 73.69 | 9.83 | 115.56 | -64.9 | -7.19 | Upgrade |
Change in Inventory | -37.95 | -37.95 | 131.98 | -171.75 | -106.51 | 67.48 | Upgrade |
Change in Accounts Payable | -155.02 | -155.02 | 100.29 | -32.04 | 338.26 | 173.89 | Upgrade |
Operating Cash Flow | 513.43 | 566.59 | 879.89 | 267.79 | 509 | 379.28 | Upgrade |
Operating Cash Flow Growth | -40.40% | -35.61% | 228.58% | -47.39% | 34.20% | -36.44% | Upgrade |
Capital Expenditures | -147.64 | -153.72 | -130.55 | -182.66 | -175.09 | -130.74 | Upgrade |
Sale of Property, Plant & Equipment | 1.4 | 1.64 | 1.81 | 1.19 | 0.49 | 34.69 | Upgrade |
Cash Acquisitions | - | - | - | - | -1.05 | -3.9 | Upgrade |
Divestitures | 10.72 | 10.72 | 25.27 | - | - | - | Upgrade |
Investment in Securities | -366.3 | -395.76 | -242.58 | -54.22 | -808.92 | 130.4 | Upgrade |
Other Investing Activities | 63.13 | 97.68 | 22 | 45.33 | 6.36 | 22.68 | Upgrade |
Investing Cash Flow | -416.08 | -416.82 | -391.57 | -25.59 | -887.81 | 106.46 | Upgrade |
Long-Term Debt Issued | - | 1,630 | 1,750 | 1,349 | 1,402 | 136.09 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | - | -3.6 | Upgrade |
Long-Term Debt Repaid | - | -1,663 | -2,149 | -1,588 | -713.77 | -377.19 | Upgrade |
Total Debt Repaid | -1,794 | -1,663 | -2,149 | -1,588 | -713.77 | -380.79 | Upgrade |
Net Debt Issued (Repaid) | -221.35 | -32.3 | -398.8 | -238.43 | 688.47 | -244.7 | Upgrade |
Issuance of Common Stock | 2.39 | 3.18 | 22.9 | 76.45 | 58.15 | 48.2 | Upgrade |
Common Dividends Paid | -264.4 | -242.9 | -67.49 | -78.6 | -172.96 | -88.03 | Upgrade |
Other Financing Activities | 281.18 | 205.52 | -55.15 | -68.28 | -0.01 | -5.26 | Upgrade |
Financing Cash Flow | -202.18 | -66.51 | -498.53 | -308.86 | 573.65 | -289.79 | Upgrade |
Foreign Exchange Rate Adjustments | -14.3 | -21.64 | -0.28 | 6.96 | -13.61 | 1.21 | Upgrade |
Net Cash Flow | -119.13 | 61.61 | -10.5 | -59.69 | 181.23 | 197.15 | Upgrade |
Free Cash Flow | 365.79 | 412.87 | 749.34 | 85.12 | 333.91 | 248.54 | Upgrade |
Free Cash Flow Growth | -49.32% | -44.90% | 780.32% | -74.51% | 34.35% | -52.75% | Upgrade |
Free Cash Flow Margin | 6.56% | 7.26% | 13.14% | 2.06% | 8.71% | 8.64% | Upgrade |
Free Cash Flow Per Share | 0.85 | 0.93 | 1.69 | 0.19 | 0.76 | 0.56 | Upgrade |
Cash Income Tax Paid | 241.26 | 206.16 | 217.76 | 137.7 | 152.49 | 125.61 | Upgrade |
Levered Free Cash Flow | 477.71 | 407.98 | 861.86 | 102.98 | 481.27 | 289.35 | Upgrade |
Unlevered Free Cash Flow | 535.64 | 465.34 | 920.09 | 158.75 | 519.31 | 314.86 | Upgrade |
Change in Net Working Capital | -89.8 | -19.4 | -492.47 | -28.06 | -390.33 | -314.65 | Upgrade |
Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.